{"product_id":"xr-ipsc-derived-cerebral-organoid-differentiation-kit","title":"XR iPSC-Derived Cerebral Organoid Differentiation Kit","description":"\u003c!--\nSEO TITLE:\nCerebral Organoid Differentiation Kit | Human iPSC\n\nMETA DESCRIPTION:\nGenerate human cerebral organoids from hPSCs using a chemically defined four-stage workflow for EB formation, neural induction, expansion, and maturation.\n\nRECOMMENDED URL:\n\/products\/cerebral-organoid-differentiation-kit\n\nPRIMARY KEYWORDS:\nCerebral Organoid Differentiation Kit\nCerebral Organoid Kit\nHuman Cerebral Organoid\niPSC Cerebral Organoid\nBrain Organoid Culture\n\nSECONDARY KEYWORDS:\nHuman Brain Organoid\nWhole Brain Organoid\nhPSC-Derived Cerebral Organoid\nCerebral Organoid Culture Kit\nNeural Organoid Culture\nEmbryoid Body Formation\nNeural Induction\nNeural Expansion\nOrganoid Maturation\nChemically Defined Medium\nHuman Pluripotent Stem Cells\nCortical Development\nForebrain Development\n3D Brain Model\nHuman Neural Development\nLong-Term Organoid Culture\n--\u003e\n\u003cstyle\u003e\n  \/* 现代专业风全局样式 *\/\n  .pdp-container {\n    font-family: -apple-system, BlinkMacSystemFont, \"Segoe UI\", Roboto, Helvetica, Arial, sans-serif;\n    color: #333333;\n    line-height: 1.6;\n    max-width: 1200px;\n    margin: 0 auto;\n    padding: 15px;\n  }\n  \n  \/* 标题样式升级 *\/\n  .pdp-container h2 {\n    font-size: 24px;\n    color: #0B3C5D;\n    border-bottom: 2px solid #328CC1;\n    padding-bottom: 8px;\n    margin-top: 40px;\n    margin-bottom: 20px;\n    font-weight: 600;\n  }\n  \n  .pdp-container h3 {\n    font-size: 18px;\n    color: #1D2731;\n    margin-top: 30px;\n    margin-bottom: 15px;\n    font-weight: 600;\n  }\n  \n  \/* 段落与列表 *\/\n  .pdp-container p {\n    margin-bottom: 16px;\n    font-size: 15px;\n    color: #4A4A4A;\n    text-align: justify;\n  }\n  \n  .pdp-container ul,\n  .pdp-container ol {\n    padding-left: 20px;\n    margin-bottom: 24px;\n  }\n  \n  .pdp-container li {\n    margin-bottom: 10px;\n    font-size: 15px;\n    color: #4A4A4A;\n  }\n\n  .pdp-container ul li {\n    list-style-type: square;\n  }\n  \n  .pdp-container li p {\n    margin-bottom: 0;\n    display: inline;\n  }\n\n  \/* 移动端表格响应式滑动容器 *\/\n  .pdp-table-responsive {\n    width: 100%;\n    overflow-x: auto;\n    -webkit-overflow-scrolling: touch;\n    margin: 25px 0;\n    border: 1px solid #E0E0E0;\n    border-radius: 6px;\n    box-shadow: 0 2px 5px rgba(0,0,0,0.05);\n  }\n  \n  .pdp-table-responsive::-webkit-scrollbar {\n    height: 6px;\n  }\n\n  .pdp-table-responsive::-webkit-scrollbar-thumb {\n    background-color: #CBCBCB;\n    border-radius: 4px;\n  }\n\n  \/* 专业表格样式 *\/\n  .pdp-table {\n    width: 100%;\n    border-collapse: collapse;\n    min-width: 600px;\n    background-color: #FFFFFF;\n    text-align: left;\n  }\n  \n  .pdp-table th,\n  .pdp-table td {\n    padding: 12px 16px;\n    border-bottom: 1px solid #E0E0E0;\n    font-size: 14px;\n    vertical-align: top;\n  }\n\n  .pdp-table th {\n    color: #FFFFFF;\n    background-color: #0B3C5D;\n    font-weight: 600;\n  }\n  \n  .pdp-table tr:last-child td {\n    border-bottom: none;\n  }\n  \n  .pdp-table tbody tr:nth-child(even) {\n    background-color: #F8F9FA;\n  }\n  \n  .pdp-table td strong {\n    color: #0B3C5D;\n    font-weight: 600;\n  }\n\n  \/* 图片自适应安全容器 *\/\n  .pdp-img-container {\n    max-width: 600px;\n    margin: 24px auto;\n    padding: 10px;\n    border: 1px solid #EEEEEE;\n    border-radius: 8px;\n    box-shadow: 0 4px 12px rgba(0, 0, 0, 0.05);\n    background: #FFFFFF;\n    box-sizing: border-box;\n    text-align: center;\n  }\n  \n  .pdp-img-container img {\n    max-width: 100%;\n    height: auto;\n    display: block;\n    margin: 0 auto;\n    border-radius: 4px;\n  }\n\n  .pdp-img-placeholder {\n    min-height: 260px;\n    display: flex;\n    align-items: center;\n    justify-content: center;\n    padding: 25px;\n    border: 1px dashed #B7C7D3;\n    border-radius: 4px;\n    background-color: #F8FAFC;\n    color: #687985;\n    font-size: 14px;\n    line-height: 1.6;\n    box-sizing: border-box;\n  }\n\n  .pdp-img-caption {\n    margin: 10px 0 0;\n    font-size: 13px !important;\n    color: #687985 !important;\n    text-align: center !important;\n  }\n\n  \/* 工作流程卡片 *\/\n  .pdp-stage {\n    margin-bottom: 16px;\n    padding: 16px 18px;\n    \n    background-color: #F8F9FA;\n    border-radius: 0 6px 6px 0;\n  }\n\n  .pdp-stage strong {\n    color: #0B3C5D;\n  }\n\n  .pdp-stage p {\n    margin: 6px 0 0;\n    text-align: left;\n  }\n\n  \/* 信息提示框 *\/\n  .pdp-note {\n    margin: 24px 0;\n    padding: 16px 18px;\n    border: 1px solid #D6E4EC;\n    border-radius: 6px;\n    background-color: #F5FAFD;\n  }\n\n  .pdp-note p {\n    margin: 0;\n    color: #405A69;\n    text-align: left;\n  }\n\n  \/* 精美FAQ折叠面板样式 *\/\n  .pdp-container details {\n    background-color: #F8F9FA;\n    border: 1px solid #E0E0E0;\n    border-radius: 6px;\n    margin-bottom: 12px;\n    padding: 14px 18px;\n    transition: all 0.3s ease;\n  }\n  \n  .pdp-container details[open] {\n    background-color: #FFFFFF;\n    border-color: #328CC1;\n    box-shadow: 0 4px 10px rgba(50, 140, 193, 0.1);\n  }\n  \n  .pdp-container summary {\n    font-weight: 600;\n    color: #0B3C5D;\n    cursor: pointer;\n    font-size: 15px;\n    outline: none;\n    user-select: none;\n  }\n  \n  .pdp-container summary:hover {\n    color: #328CC1;\n  }\n  \n  .pdp-container details p {\n    margin-top: 12px;\n    margin-bottom: 0;\n    padding-top: 12px;\n    border-top: 1px dashed #E0E0E0;\n    color: #555555;\n  }\n\n  \/* 手机端间距微调 *\/\n  @media (max-width: 768px) {\n    .pdp-container h2 {\n      font-size: 20px;\n      margin-top: 30px;\n    }\n\n    .pdp-container h3 {\n      font-size: 16px;\n    }\n\n    .pdp-container p,\n    .pdp-container li {\n      font-size: 14px;\n    }\n\n    .pdp-img-placeholder {\n      min-height: 200px;\n    }\n  }\n\u003c\/style\u003e\n\u003cdiv class=\"pdp-container\"\u003e\n\u003ch2\u003eDescription\u003c\/h2\u003e\n\u003cp\u003eGenerating human cerebral organoids from induced pluripotent stem cells can be affected by uneven embryoid body formation, variable neural induction, inconsistent extracellular matrix embedding, and insufficient nutrient exchange during long-term three-dimensional culture. These variables may influence organoid size, optical density, neural tissue expansion, and the formation of cortical-like regions.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eXR Cerebral Organoid Differentiation Kit\u003c\/strong\u003e is a chemically defined, four-stage culture system designed to differentiate human pluripotent stem cells, including human induced pluripotent stem cells and human embryonic stem cells, into three-dimensional cerebral organoids. The staged workflow guides cultures through embryoid body formation, neural induction, neural tissue expansion, matrix-supported growth, and orbital maturation.\u003c\/p\u003e\n\u003cp\u003eThe resulting hPSC-derived cerebral organoids can develop into large, optically dense structures containing multiple neural lineages and observable cortical-like regions. This human brain organoid culture system provides researchers with a structured workflow for studying early human cortical development and characterizing three-dimensional neural tissue formation.\u003c\/p\u003e\n\u003cp\u003eEach kit contains four stage-specific cerebral organoid media and supports the generation of approximately 48 organoids when used according to the recommended workflow.\u003c\/p\u003e\n\u003ch2\u003eSpecifications\u003c\/h2\u003e\n\u003cdiv class=\"pdp-table-responsive\"\u003e\n\u003ctable class=\"pdp-table\"\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eProduct Name\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eXR Cerebral Organoid Differentiation Kit\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eSKU\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eXR-iCereOrg-Kit\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eProduct Type\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eCerebral organoid differentiation medium kit\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eStarting Cells\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eHuman pluripotent stem cells, including iPSCs and hESCs\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eCulture Format\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eEmbryoid body-based three-dimensional organoid culture\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eDifferentiation Strategy\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eFour-stage directed differentiation workflow\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eMedium A\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e30 mL\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eMedium B\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e30 mL\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eMedium C\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e30 mL\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eMedium D\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e160 mL\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eApproximate Yield\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eApproximately 48 cerebral organoids per kit\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eInitial Plate Format\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e96-well low-attachment U-bottom plate\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eExpansion Plate Format\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e24-well low-attachment plate\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eOrbital Culture Speed\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e65–75 rpm during the maturation stage\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eRecommended Culture Period\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e40 days or longer, depending on the required organoid size and experimental endpoint\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eFormulation\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eChemically defined, stage-specific culture system\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eGrade\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eResearch use only\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003ch2\u003eKit Components\u003c\/h2\u003e\n\u003cdiv class=\"pdp-table-responsive\"\u003e\n\u003ctable class=\"pdp-table\"\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eComponent\u003c\/th\u003e\n\u003cth\u003eVolume\u003c\/th\u003e\n\u003cth\u003eWorkflow Stage\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eCerebral Organoid Induction Medium A\u003c\/td\u003e\n\u003ctd\u003e30 mL\u003c\/td\u003e\n\u003ctd\u003eEmbryoid body formation\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCerebral Organoid Induction Medium B\u003c\/td\u003e\n\u003ctd\u003e30 mL\u003c\/td\u003e\n\u003ctd\u003eNeural induction\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCerebral Organoid Induction Medium C\u003c\/td\u003e\n\u003ctd\u003e30 mL\u003c\/td\u003e\n\u003ctd\u003eMatrix-embedded neural expansion\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCerebral Organoid Induction Medium D\u003c\/td\u003e\n\u003ctd\u003e160 mL\u003c\/td\u003e\n\u003ctd\u003eOrbital culture and organoid maturation\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003ch2\u003eFeatures\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003eFour-stage cerebral organoid differentiation workflow designed for human pluripotent stem cells\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eChemically defined culture system for controlled stage-specific neural differentiation\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eSupports embryoid body formation in low-attachment U-bottom plates\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eGuides cultures through neural induction, matrix embedding, neural expansion, and long-term maturation\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eDesigned to generate large, optically dense human cerebral organoids\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eSupports the development of multiple neural lineages and observable cortical-like regions\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eIncludes sufficient stage-specific media for approximately 48 cerebral organoids\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eCompatible with extended orbital culture at 65–75 rpm from Day 14 onward\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eSuitable for iPSC cerebral organoid and hESC cerebral organoid research workflows\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eCerebral Organoid Differentiation Workflow\u003c\/h2\u003e\n\u003cp\u003eThe recommended protocol begins with healthy human pluripotent stem cell cultures at approximately 80% confluency. Cells are dissociated into single cells before sequential exposure to the four stage-specific media.\u003c\/p\u003e\n\u003cdiv class=\"pdp-stage\"\u003e\n\u003cstrong\u003eStage 1: Day 0–6 — Embryoid Body Formation\u003c\/strong\u003e\n\u003cp\u003eDissociate iPSCs or other hPSCs into single cells and seed them into a 96-well low-attachment U-bottom plate using Cerebral Organoid Induction Medium A. Continue EB culture through Day 6 with medium replacement every other day.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pdp-stage\"\u003e\n\u003cstrong\u003eStage 2: Day 7–10 — Neural Induction\u003c\/strong\u003e\n\u003cp\u003eTransfer the developing organoids into a 24-well low-attachment plate and replace the medium with Cerebral Organoid Induction Medium B. Maintain the cultures under static conditions and replace the medium every other day.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pdp-stage\"\u003e\n\u003cstrong\u003eStage 3: Day 11–13 — Matrix Embedding and Neural Expansion\u003c\/strong\u003e\n\u003cp\u003eEmbed each developing organoid in an extracellular matrix gel and return it to a 24-well low-attachment plate. Culture with Cerebral Organoid Induction Medium C under static conditions, replacing the medium every other day.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pdp-stage\"\u003e\n\u003cstrong\u003eStage 4: Day 14–40+ — Orbital Culture and Maturation\u003c\/strong\u003e\n\u003cp\u003ePlace the 24-well low-attachment plate on an orbital shaker at 65–75 rpm and change to Cerebral Organoid Induction Medium D. Replace the medium every other day and continue culture until the organoids reach the size required for the planned experiment.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pdp-note\"\u003e\n\u003cp\u003e\u003cstrong\u003eImportant:\u003c\/strong\u003e Organoid differentiation performance can be influenced by the quality, confluency, dissociation condition, viability, and pluripotency status of the starting hPSC culture. Matrix handling and orbital culture conditions should also be kept consistent between experiments.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c!-- IMAGE 2 POSITION: Differentiation timeline and organoid morphology --\u003e\n\u003cdiv class=\"pdp-img-container\" style=\"text-align: center;\"\u003e\u003cimg height=\"auto\" width=\"1200\" loading=\"lazy\" alt=\"Human iPSC cerebral organoid differentiation timeline showing embryoid body formation neural induction matrix embedding and orbital maturation\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0521\/5312\/2997\/files\/1_1_bba32a09-8dc6-4188-8938-aca87b150a9f.jpg?v=1784007431\" style=\"float: none;\"\u003e\u003c\/div\u003e\n\u003ch2\u003ePerformance and Characterization Data\u003c\/h2\u003e\n\u003ch3\u003eProgressive Three-Dimensional Organoid Formation\u003c\/h3\u003e\n\u003cp\u003eThe source data show a staged morphological transition from adherent iPSC culture to compact embryoid bodies, followed by neural induction, neural tissue expansion, and formation of a large cerebral organoid. The Day 40+ morphology demonstrates the continued three-dimensional growth supported by the maturation medium and orbital culture stage.\u003c\/p\u003e\n\u003ch3\u003eNeural and Cortical Marker Expression\u003c\/h3\u003e\n\u003cp\u003eImmunofluorescence images provided with the kit show expression of neural development-associated markers, including TUJ, PAX6, CTIP2, and FOXG1. Together, these markers are used to characterize neuronal differentiation, neural progenitor populations, cortical neuronal development, and forebrain-associated identity within the generated organoids.\u003c\/p\u003e\n\u003cdiv class=\"pdp-table-responsive\"\u003e\n\u003ctable class=\"pdp-table\"\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eMarker\u003c\/th\u003e\n\u003cth\u003eCommon Research Association\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eTUJ\u003c\/td\u003e\n\u003ctd\u003eNeuronal differentiation and neuronal structures\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePAX6\u003c\/td\u003e\n\u003ctd\u003eNeural progenitor and neuroectoderm-associated populations\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCTIP2\u003c\/td\u003e\n\u003ctd\u003eDeep-layer cortical neuron-associated differentiation\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFOXG1\u003c\/td\u003e\n\u003ctd\u003eForebrain-associated neural development\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c!-- IMAGE 3 POSITION: Neural marker immunofluorescence panels --\u003e\n\u003cdiv class=\"pdp-img-container\" style=\"text-align: center;\"\u003e\u003cimg height=\"auto\" width=\"1200\" loading=\"lazy\" alt=\"TUJ PAX6 CTIP2 and FOXG1 immunofluorescence staining in human iPSC derived cerebral organoids\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0521\/5312\/2997\/files\/1_1_0bfee34b-8a6e-4fe9-8c04-6b4f0261c637.jpg?v=1784007181\" style=\"float: none;\"\u003e\u003c\/div\u003e\n\u003ch2\u003eApplications\u003c\/h2\u003e\n\u003cp\u003eXR Cerebral Organoid Differentiation Kit is intended for research workflows requiring a three-dimensional human neural model derived from pluripotent stem cells. The four-stage system supports experimental designs focused on organoid generation, early neural differentiation, cortical-like tissue organization, and characterization of hPSC-derived brain tissue.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eHuman cerebral organoid generation:\u003c\/strong\u003e Differentiation of human iPSCs or hESCs into three-dimensional cerebral organoids through an EB-based workflow.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eEarly human brain development research:\u003c\/strong\u003e Study of cellular and structural changes associated with early neural and cerebral tissue development in vitro.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eCortical development studies:\u003c\/strong\u003e Investigation of cortical-like region formation and expression of development-associated markers such as PAX6 and CTIP2.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eForebrain development research:\u003c\/strong\u003e Generation and characterization of neural tissue expressing the forebrain-associated marker FOXG1.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eNeural induction studies:\u003c\/strong\u003e Evaluation of the transition from pluripotent stem cells and embryoid bodies toward neuroectodermal and neural progenitor populations.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eNeuronal differentiation research:\u003c\/strong\u003e Characterization of neuronal development and TUJ-positive structures in a three-dimensional organoid environment.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eHuman iPSC line comparison:\u003c\/strong\u003e Comparison of cerebral organoid formation between different human induced pluripotent stem cell lines under a common staged protocol.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eGene function research:\u003c\/strong\u003e Phenotypic characterization of genetically modified hPSC lines during cerebral organoid differentiation.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eOrganoid morphology analysis:\u003c\/strong\u003e Assessment of EB formation, optical density, neural tissue expansion, organoid size, and structural development over time.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eLong-term neural organoid culture:\u003c\/strong\u003e Continued orbital culture beyond Day 40 for studies requiring larger or more developed cerebral organoids.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eThree-dimensional neural model research:\u003c\/strong\u003e Use of hPSC-derived cerebral organoids as in vitro 3D brain models for basic neurodevelopmental research.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eNeural marker characterization:\u003c\/strong\u003e Immunofluorescence analysis of markers associated with neurons, neural progenitors, cortical neurons, and forebrain identity.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eKey Workflow Considerations\u003c\/h2\u003e\n\u003ch3\u003eStarting Cell Quality\u003c\/h3\u003e\n\u003cp\u003eBegin differentiation with healthy, actively growing hPSC cultures at approximately 80% confluency. Cultures showing substantial spontaneous differentiation, low viability, or irregular colony morphology may produce less consistent embryoid bodies.\u003c\/p\u003e\n\u003ch3\u003eSingle-Cell Dissociation\u003c\/h3\u003e\n\u003cp\u003eConsistent single-cell preparation is important for generating uniform EBs in the 96-well low-attachment U-bottom plate. Excessive mechanical stress or prolonged dissociation may reduce cell viability and affect early aggregate formation.\u003c\/p\u003e\n\u003ch3\u003eExtracellular Matrix Embedding\u003c\/h3\u003e\n\u003cp\u003eDuring Days 11–13, developing organoids are embedded in an extracellular matrix gel. Consistent matrix volume, handling temperature, and positioning can help reduce variation in neural tissue expansion between organoids.\u003c\/p\u003e\n\u003ch3\u003eOrbital Culture\u003c\/h3\u003e\n\u003cp\u003eFrom Day 14 onward, orbital culture at 65–75 rpm supports medium movement around the developing organoids. Shaker speed, plate position, working volume, and medium replacement schedule should remain consistent throughout the maturation phase.\u003c\/p\u003e\n\u003ch2\u003eWhy Choose XR Cerebral Organoid Differentiation Kit?\u003c\/h2\u003e\n\u003cp\u003eCerebral organoid generation is a multistage process in which variation during EB formation, neural induction, matrix embedding, or maturation can affect the final organoid phenotype. Researchers therefore require more than a general neural differentiation medium; they need a coordinated workflow that supports each developmental stage with the appropriate culture environment.\u003c\/p\u003e\n\u003cp\u003eXR Cerebral Organoid Differentiation Kit provides four stage-specific media organized around the major steps of human cerebral organoid culture. The workflow begins with controlled embryoid body formation and progresses through neural induction, matrix-supported expansion, and long-term orbital maturation. This structure helps laboratories standardize the timing and medium transitions used during iPSC cerebral organoid differentiation.\u003c\/p\u003e\n\u003cp\u003eThe kit also provides sufficient medium to generate approximately 48 organoids and includes characterization data for TUJ, PAX6, CTIP2, and FOXG1 expression. It is therefore suitable for laboratories developing reproducible hPSC-derived cerebral organoid workflows for early human neural and cortical development research.\u003c\/p\u003e\n\u003ch2\u003eFAQ\u003c\/h2\u003e\n\u003cdetails\u003e\n\u003csummary\u003eWhat is the XR Cerebral Organoid Differentiation Kit used for?\u003c\/summary\u003e\n\u003cp\u003eXR Cerebral Organoid Differentiation Kit is used to differentiate human pluripotent stem cells, including iPSCs and hESCs, into three-dimensional cerebral organoids through a four-stage culture workflow.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003eWhat types of cells can be used to generate cerebral organoids with this kit?\u003c\/summary\u003e\n\u003cp\u003eThe kit is designed for human pluripotent stem cells, including human induced pluripotent stem cells and human embryonic stem cells. Starting cultures should be healthy and display suitable pluripotent stem cell morphology before differentiation.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003eIs this an iPSC cerebral organoid differentiation kit?\u003c\/summary\u003e\n\u003cp\u003eYes. The system supports iPSC cerebral organoid differentiation beginning with single-cell dissociation and EB formation, followed by neural induction, matrix embedding, neural expansion, and orbital maturation.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003eWhat is included in the cerebral organoid kit?\u003c\/summary\u003e\n\u003cp\u003eThe kit contains 30 mL of Cerebral Organoid Induction Medium A, 30 mL of Medium B, 30 mL of Medium C, and 160 mL of Medium D. Each medium is used during a different stage of the differentiation workflow.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003eHow many human cerebral organoids can be generated with one kit?\u003c\/summary\u003e\n\u003cp\u003eOne kit provides sufficient stage-specific media to generate approximately 48 cerebral organoids when used according to the recommended culture workflow.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003eHow long does cerebral organoid differentiation take?\u003c\/summary\u003e\n\u003cp\u003eThe initial workflow extends through Day 40 or longer. EB formation occurs during Days 0–6, neural induction during Days 7–10, matrix-embedded expansion during Days 11–13, and orbital maturation begins on Day 14.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003eDoes this cerebral organoid culture workflow use embryoid bodies?\u003c\/summary\u003e\n\u003cp\u003eYes. Human pluripotent stem cells are dissociated into single cells and cultured in a 96-well low-attachment U-bottom plate to form embryoid bodies before neural induction.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003eIs extracellular matrix embedding required?\u003c\/summary\u003e\n\u003cp\u003eYes. According to the recommended protocol, developing organoids are embedded in an extracellular matrix gel during Days 11–13 before the long-term orbital maturation stage.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003eWhat orbital shaker speed is recommended for organoid maturation?\u003c\/summary\u003e\n\u003cp\u003eThe recommended orbital culture speed is 65–75 rpm beginning on Day 14. Laboratories should maintain consistent plate position, culture volume, and shaker conditions throughout long-term cerebral organoid culture.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003eWhat markers were used to characterize the generated cerebral organoids?\u003c\/summary\u003e\n\u003cp\u003eThe product data include immunofluorescence images for TUJ, PAX6, CTIP2, and FOXG1. These markers are commonly associated with neuronal differentiation, neural progenitor populations, cortical neuronal development, and forebrain identity.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003eCan the kit be used to study cortical development?\u003c\/summary\u003e\n\u003cp\u003eThe generated organoids can contain observable cortical-like regions, and the supplied data include PAX6 and CTIP2 staining. The system is therefore suitable for research involving early cortical-like tissue development and neural differentiation.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003eIs the culture medium chemically defined?\u003c\/summary\u003e\n\u003cp\u003eYes. XR Cerebral Organoid Differentiation Kit is described as a chemically defined, stage-specific differentiation system for human cerebral organoid culture.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003eCan cerebral organoids be cultured beyond Day 40?\u003c\/summary\u003e\n\u003cp\u003eYes. The protocol indicates that orbital culture with Medium D can continue beyond Day 40 until the organoids reach the size required for the planned research endpoint.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cdetails\u003e\n\u003csummary\u003eIs this product intended for clinical or diagnostic use?\u003c\/summary\u003e\n\u003cp\u003eNo. XR Cerebral Organoid Differentiation Kit is intended for research use only and is not intended for diagnostic, therapeutic, or clinical applications.\u003c\/p\u003e\n\u003c\/details\u003e\n\u003cp\u003e\u003cem\u003eFor Research Use Only. Not for use in diagnostic or therapeutic procedures.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"XRbio","offers":[{"title":"1Kit","offer_id":52798294589621,"sku":"XR-iCereOrg-Kit","price":0.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0521\/5312\/2997\/files\/2_331e54b0-0e7d-4609-8e9f-764ad7b42c8f.jpg?v=1784006765","url":"https:\/\/biofargo.com\/products\/xr-ipsc-derived-cerebral-organoid-differentiation-kit","provider":"Biofargo","version":"1.0","type":"link"}